Beyond Air gets Nasdaq extension to regain bid price compliance by July 31 Jun 1, 2026 08:03AM
Beyond Air secures group purchasing agreement for LungFit PH system Apr 1, 2026 09:01AM
BTIG reiterates Neutral rating on Beyond Air (XAIR) amid CEO change Mar 26, 2026 05:46PM
Beyond Air comments on review article about high-dose nitric oxide therapy Feb 20, 2026 08:01AM
Beyond Air, Inc. (XAIR) reported Q3 EPS ; Offers Guidance Feb 14, 2026 01:39PM


Jan 20, 2026 07:36AM Rodman & Renshaw Starts Beyond Air (XAIR) at Buy
Jan 13, 2026 09:28AM XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
Jan 13, 2026 07:31AM XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Dec 17, 2025 07:31AM Beyond Air expands LungFit PH distribution to 39 countries
Nov 21, 2025 04:08PM Beyond Air, Inc. (XAIR) files for 1.6M share offering by selling stockholders
Nov 10, 2025 04:37PM Beyond Air, Inc. (XAIR) Misses Q2 EPS by 116c
Nov 5, 2025 08:01AM Beyond Air secures $32 million financing from Streeterville Capital
Sep 8, 2025 03:59PM Beyond Air raises $3.25 million through warrant exercise agreement
Sep 8, 2025 08:02AM NeuroNOS receives FDA orphan drug designation for glioblastoma treatment
Aug 20, 2025 08:01AM Beyond Air expands LungFit PH distribution to Japan and five other countries
Aug 13, 2025 09:11AM Beyond Air (XAIR) PT Lowered to $5 at Piper Sandler
Aug 12, 2025 04:30PM Beyond Air, Inc. (XAIR) Misses Q1 EPS by 43c
Jul 22, 2025 07:30AM Beyond Air wins Premier group purchasing agreement for therapeutic gases
Jul 17, 2025 07:09AM D. Boral Capital Starts Beyond Air (xair) at Buy
Jun 17, 2025 04:02PM Beyond Air, Inc. (XAIR) Tops Q4 EPS by 6c, Misses on Revenue
Apr 21, 2025 04:07PM Beyond Air's (XAIR) NeuroNOS receives FDA orphan drug designation for BA-102
Apr 15, 2025 04:06PM Beyond Air, Inc. (XAIR) subsidiary NeuroNOS appoints Dan Shechtman to SAB
Apr 1, 2025 08:00AM Beyond Air, Inc. (XAIR) Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Di
Mar 11, 2025 07:30AM Beyond Air, Inc. (XAIR) Announces Agreements Expanding Global Distribution of LungFit PH
Feb 11, 2025 07:04AM BTIG Reiterates Neutral Rating on Beyond Air (XAIR)
Feb 10, 2025 04:07PM Beyond Air, Inc. (XAIR) Reports In-Line Q3 EPS, Beats on Revenue
Feb 5, 2025 09:30AM Beyond Air, Inc. (XAIR) granted extension by Nasdaq to regain compliance with minimum bid price
Jan 31, 2025 09:08AM Jones Trading Starts Beyond Air (XAIR) at Buy
Jan 24, 2025 09:16AM Beyond Air, Inc. (XAIR) Announces LungFit PH Receives Market Authorization in Australia
Dec 2, 2024 07:31AM Beyond Air, Inc. (XAIR) Receives CE Mark in Europe for the LungFit PH System
Nov 12, 2024 08:00AM Piper Sandler Reiterates Overweight Rating on Beyond Air (XAIR)
Nov 11, 2024 04:09PM Beyond Air, Inc. (XAIR) Reports In-Line Q2 EPS
Oct 25, 2024 04:13PM Beyond Air, Inc. (XAIR) Files for 81.7M Share Offering by Selling Stockholders
Oct 2, 2024 07:30AM Beyond Air (XAIR) Partners with Healthcare Links to Expand Access to LungFit PH System Through Group Purchasing Organizations and Integrated Delivery Networks
Sep 27, 2024 07:35AM Beyond Air, Inc. (XAIR) Provides LungFit PH System to U.S. Naval Hospital Guam
Sep 27, 2024 07:32AM Beyond Air, Inc. (XAIR) Announces Termination of the Loan and Security Agreements with Avenue Capital
Sep 27, 2024 07:30AM Beyond Air, Inc. (XAIR) Announces $20.6M Share Offering
Aug 16, 2024 05:22AM Roth/MKM Resumes Beyond Air (XAIR) at Buy
Aug 7, 2024 07:41AM Beyond Air (XAIR) PT Lowered to $1 at Piper Sandler
Aug 6, 2024 04:55PM Beyond Air, Inc. (XAIR) Tops Q1 EPS by 7c
Jun 25, 2024 05:36AM BTIG Downgrades Beyond Air (XAIR) to Neutral
Jun 24, 2024 04:34PM Beyond Air, Inc. (XAIR) Misses Q4 EPS by 133c
Jun 13, 2024 04:06PM Beyond Air (XAIR) Appoints David Webster as Chief Commercial Officer